SAN DIEGO, June 22, 2016 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that it has been added to the preliminary list of new additions to join the Russell Microcap Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective after the U.S. market opens on June 27.
Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
Indexes provided by FTSE Russell, a leading global index provider, are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $6 trillion in assets are benchmarked against the Russell US Indexes.
For more information on the Russell Microcap(®) Index and the Russell US Indexes reconstitution, go to the "Russell Reconstitution" section on the FTSE Russell website.